We have negotiated clinical trial agreements on behalf of several sponsors.
Updates
Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.
Type
Sectors
Expertises (2)
19 results
Newest first
We have advised on commercial contracting and borderline classification cases.
We have advised an importers, distributors on a complex international supply chain strategy under the MDR.
We have advised a large MedTech company on the structuring of its collaboration with Dutch healthcare providers and healthcare professionals for clinical research and product development purposes.
We have advised a start-up on the legal limitations and requirements related to the transport of dangerous substances.
Our team negotiated a cooperation agreement between a cosmetics brand owner and a manufacturer on behalf of a mid-sized company.
Our team assisted a mid-sized cosmetics company with the negotiation of a distribution agreement.
Axon advised a stock-listed biopharmaceutical company on antibody licensing and technology transfer agreements with two major US-based pharmaceutical companies. The deals involved the grant of commercial rights to the licensor's proprietary antibody platform technology.
Axon regularly advises spin-outs from academic institutions on a wide range of topics. We make sure that the spin-out’s license agreement includes commercially and legally viable terms and is attractive to investors. In addition, we advise on the corporate structure of the spin-out, balancing the interest of the founders, the academic institution and all other stakeholders.